Toxin-producing yeast strains in gut fuel IBD

Individual Candida albicans yeast strains in the human gut are as different from each other as the humans that carry them, and some C. albicans strains may damage the gut of patients with inflammatory bowel disease, according to a new study from researchers at Weill Cornell Medicine.

Enzyme could be new target for cancer immunotherapies

Tumors can use an enzyme called ART1 to thwart antitumor immune cells, making the enzyme a promising new target for immunity-boosting cancer treatments, according to a study from researchers at Weill Cornell Medicine and Albert Einstein College of Medicine.

Delayed consciousness is common for COVID patients on respirators

Most patients with severe COVID who are put on ventilators regain consciousness after removal of respiratory support, but recovery may take weeks after the period of mechanical ventilation has ended, according to a new study.

Hotel Ezra Cornell drink winners play up pineapple

The student-created signature drinks for Hotel Ezra Cornell 97 to celebrate the Nolan School of Hotel Administration’s centennial, feature the humble pineapple, long a hospitality symbol.

Cornell, partners seek to grow STEM recruiting program

A summit hosted at Cornell Tech on Feb. 28 brought together more than 50 principals, guidance counselors, students and leaders from community-based organizations to discuss how to grow Cornell’s Bridge Scholars program from a successful pilot initiative into a nation-wide collaborative.

Hormone may contribute to infertility in PCOS

Anti-Mullerian hormone, traditionally thought of as a passive byproduct of polycystic ovary syndrome, may actually play an active role in the disorder, according to new research.

Creating Our Robotic Allies

When we think of having our own handy multi-purpose robots, we tend to picture something out of Star Wars or The Jetsons — but the useful technology of the ‘future’ may not be as far off as we think. Maria Bauza Villalonga, PhD student at MIT, hosted a Seminar @ Cornell Tech to show how robots can become our best allies.

Around Cornell

Discovery may help reduce side effects of MS drugs

Investigators from Weill Cornell Medicine and Memorial Sloan Kettering Cancer Center have discovered how a drug for multiple sclerosis interacts with its targets, a finding that may pave the way for better treatments.

Grant from Meta to spark Cornell research into AR, VR

Powering augmented and virtual reality technologies to tackle real-world problems is the focus of a two-year, $1.8 million grant from Meta and Spark AR to Cornell Bowers CIS and Cornell Tech’s XR Collaboratory.

Staff News